Supplementary Fig. S4 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer Francisco Hermida-Prado , Yingtian Xie , Shira Sherman , Zsuzsanna Nagy , Douglas Russo , Tara Akhshi , Zhengtao Chu , Avery Feit , Marco Campisi , Minyue Chen , Agostina Nardone , Cristina Guarducci , Klothilda Lim , Alba Font-Tello , Irene Lee , Juana García-Pedrero , Israel Cañadas , Judith Agudo , Ying Huang , Tal Sella , Qingchun Jin , Nabihah Tayob , Elizabeth A. Mittendorf , Sara M. Tolaney , Xintao Qiu , Henry Long , William F. Symmans , Jia-Ren Lin , Sandro Santagata , Isabelle Bedrosian , Denise A. Yardley , Ingrid A. Mayer , Edward T. Richardson , Giacomo Oliveira , Catherine J. Wu , Eugene F. Schuster , Mitch Dowsett , Alana L. Welm , David Barbie , Otto Metzger , Rinath Jeselsohn crossref（2023）
摘要
Supplementary Fig. S4. Schematic of flow cytometry experiments and differential impact of IFNg stimulation on HR+ breast cancer cells.
更多 查看译文
关键词
endocrine therapy synergizes, hormone receptor–positive, smac mimetics, breast cancer
AI 理解论文
溯源树
样例
